Bella Donna Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Bella Donna Pharma
Largest movements
- Tangible fixed assets -€32,017
down €32,017 (-7.5%), from €425,891 to €393,873
of which Land and buildings: -€17,083
- Cash -€31,529
down €31,529 (-43.9%), from €71,760 to €40,232
mainly Debts after one year (-€58,125) and Net result for the year (-€35,953)
- Intangible fixed assets -€26,500
down €26,500 (-50.0%), from €53,000 to €26,500
- Receivables within one year +€19,133
up €19,133 (+40.5%), from €47,199 to €66,332
of which Other amounts receivable: +€10,028
- Stocks and contracts +€9,264
up €9,264 (+8.0%), from €115,143 to €124,407
- Debts after one year -€58,125
down €58,125 (-13.7%), from €424,394 to €366,268
- Profit (loss) carried forward -€35,953
down €35,953, from €31,864 to -€4,088
- Trade debts +€15,951
up €15,951 (+25.6%), from €62,276 to €78,227
- Other debts +€8,179
up €8,179 (+7.2%), from €113,429 to €121,608
- Gross operating margin -€49,267
down €49,267 (-32.3%), from €152,606 to €103,339
- Staff costs -€6,522
down €6,522 (-8.9%), from €73,028 to €66,506
- Other operating charges -€3,900
down €3,900 (-60.9%), from €6,401 to €2,501
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €721,530 | €655,308 | -€66,222 | -9.2% |
| Fixed assets | 21/28 | €478,891 | €420,373 | -€58,517 | -12.2% |
| Intangible fixed assets | 21 | €53,000 | €26,500 | -€26,500 | -50.0% |
| Tangible fixed assets | 22/27 | €425,891 | €393,873 | -€32,017 | -7.5% |
| Land and buildings | 22 | €397,184 | €380,101 | -€17,083 | -4.3% |
| Plant, machinery and equipment | 23 | €28,016 | €13,497 | -€14,519 | -51.8% |
| Furniture and vehicles | 24 | €690 | €275 | -€415 | -60.1% |
| Current assets | 29/58 | €242,640 | €234,935 | -€7,705 | -3.2% |
| Stocks and contracts in progress | 3 | €115,143 | €124,407 | +€9,264 | +8.0% |
| Stocks | 30/36 | €115,143 | €124,407 | +€9,264 | +8.0% |
| Amounts receivable within one year | 40/41 | €47,199 | €66,332 | +€19,133 | +40.5% |
| Trade receivables | 40 | €45,368 | €54,473 | +€9,105 | +20.1% |
| Other amounts receivable | 41 | €1,830 | €11,858 | +€10,028 | +548% |
| Cash at bank and in hand | 54/58 | €71,760 | €40,232 | -€31,529 | -43.9% |
| Deferred charges and accrued income | 490/1 | €8,538 | €3,965 | -€4,573 | -53.6% |
| Total equity and liabilities | 10/49 | €721,530 | €655,308 | -€66,222 | -9.2% |
| Equity | 10/15 | €52,645 | €16,693 | -€35,953 | -68.3% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €781 | €781 | = | 0.0% |
| Non-distributable reserves | 130/1 | €781 | €781 | = | 0.0% |
| Reserves not available under the articles | 1311 | €781 | €781 | = | 0.0% |
| Profit (loss) carried forward | 14 | €31,864 | -€4,088 | -€35,953 | |
| Amounts payable | 17/49 | €668,885 | €638,615 | -€30,269 | -4.5% |
| Amounts payable after more than one year | 17 | €424,394 | €366,268 | -€58,125 | -13.7% |
| Financial debts | 170/4 | €424,394 | €366,268 | -€58,125 | -13.7% |
| Amounts payable within one year | 42/48 | €242,439 | €269,988 | +€27,549 | +11.4% |
| Current portion of amounts payable after more than one year | 42 | €57,164 | €58,125 | +€961 | +1.7% |
| Trade debts | 44 | €62,276 | €78,227 | +€15,951 | +25.6% |
| Suppliers | 440/4 | €62,276 | €78,227 | +€15,951 | +25.6% |
| Taxes, remuneration and social security | 45 | €9,571 | €12,028 | +€2,457 | +25.7% |
| Taxes | 450/3 | €2,457 | €1,615 | -€842 | -34.3% |
| Remuneration and social security | 454/9 | €7,114 | €10,413 | +€3,299 | +46.4% |
| Other amounts payable | 47/48 | €113,429 | €121,608 | +€8,179 | +7.2% |
| Accrued charges and deferred income | 492/3 | €2,052 | €2,359 | +€307 | +15.0% |
| Remuneration, social security and pensions | 62 | €73,028 | €66,506 | -€6,522 | -8.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €59,978 | €58,517 | -€1,461 | -2.4% |
| Other operating charges | 640/8 | €6,401 | €2,501 | -€3,900 | -60.9% |
| Gross operating margin | 9900 | €152,606 | €103,339 | -€49,267 | -32.3% |
| Operating profit (loss) | 9901 | €13,199 | -€24,186 | -€37,385 | |
| Financial income | 75/76B | €1,049 | €1,114 | +€65 | +6.2% |
| Recurring financial income | 75 | €1,049 | €1,114 | +€65 | +6.2% |
| Financial charges | 65/66B | €12,948 | €12,882 | -€66 | -0.5% |
| Recurring financial charges | 65 | €12,948 | €12,882 | -€66 | -0.5% |
| Profit (loss) for the period before taxes | 9903 | €1,300 | -€35,953 | -€37,253 | |
| Income taxes | 67/77 | €968 | - | -€968 | |
| Profit (loss) for the period | 9904 | €333 | -€35,953 | -€36,285 | |
| Profit (loss) for the period to be appropriated | 9905 | €333 | -€35,953 | -€36,285 |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.